Breath based biomarker detection: informing drug development and future treatment regimes
Non-invasive biomarkers are becoming important components of precision medicine-based drug treatment regimes. This article published in Drug Discovery World highlights the shifting focus of precision medicine to a metabolomics approach.
This free download includes information about:
- The inherent advantages of Breath Biopsy®
- Use of Volatile Organic Compounds (VOC) biomarkers in translational medicine
- Exhaled breath analysis in diagnosis & treatment of pulmonary diseases